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Summary
Nanophthalmos is an uncommon developmental ocular
disorder characterized by a small eye, as indicated by
short axial length, high hyperopia (severe farsighted-
ness), high lens/eye volume ratio, and a high incidence
of angle-closure glaucoma. We performed clinical and
genetic evaluations of members of a large family in
which nanophthalmos is transmitted in an autosomal
dominant manner. Ocular examinations of 22 affected
family members revealed high hyperopia (range
7.25–13.00 diopters; mean 9.88 diopters) and
short axial length (range 17.55–19.28 mm; mean 18.13
mm). Twelve affected family members had angle-closure
glaucoma or occludable anterior-chamber angles. Link-
age analysis of a genome scan demonstrated highly sig-
nificant evidence that nanophthalmos in this family is
the result of a defect in a previously unidentified locus
(NNO1) on chromosome 11. The gene was localized to
a 14.7-cM interval between D11S905 and D11S987,
with a maximum LOD score of 5.92 at a recombination
fraction of .00 for marker D11S903 and a multipoint
maximum LOD score of 6.31 for marker D11S1313.
NNO1 is the first human locus associated with nanoph-
thalmos or with an angle-closure glaucoma phenotype,
and the identification of the NNO1 locus is the first step
toward the cloning of the gene. A cloned copy of the
gene will enable examination of the relationship, if any,
between nanophthalmos and less severe forms of hy-
peropia and between nanophthalmos and other condi-
tions in which angle-closure glaucoma is a feature.
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Introduction
Nanophthalmos, sometimes referred to as “simple (or
pure) microphthalmos” (Brockhurst 1974; Weiss et al.
1989; Vingolo et al. 1994), is a relatively rare condition
characterized by a small eye (globe) in the absence of
any systemic abnormalities. Both autosomal recessive
and autosomal dominant inheritance have been reported
for nanophthalmos (Martorina 1988; Diehl et al. 1989;
Vingolo et al. 1994). The major clinical characteristics
of the nanophthalmic eye include a short axial length,
a high degree of hyperopia (farsightedness), a high lens/
eye volume ratio, a small corneal diameter, and a high
occurrence of angle-closure glaucoma (Duke-Elder
1964; Kimbrough et al. 1979; Singh et al. 1982).
Nanophthalmos can result in severe visual conse-
quences. Nanophthalmic individuals are farsighted be-
cause the shortened axial length causes the focal point
to fall behind the retina, a condition that can be treated
with appropriate corrective lenses. Children who are not
diagnosed early enough in life can develop amblyopia
(lazy eye), which can be irreversible. Angle-closure glau-
coma results from obstruction of the eye’s outflow chan-
nels (trabecular meshwork) by the iris, which can pro-
duce increased intraocular pressure and subsequent
damage to the optic nerve. The strong association of
angle-closure glaucoma with nanophthalmos is thought
to result from the ocular anatomical abnormalities seen
in this condition (Brockhurst 1974; Kimbrough et al.
1979). Although medical treatment and laser surgery can
be used to successfully manage angle-closure glaucoma
in the nanophthalmic eye, untreated angle-closure glau-
coma can result in blindness. In addition, complications
following any type of intraocular surgery in the nano-
phthalmic eye are common and can cause severe loss of
vision (Singh et al. 1982).
We began our investigation of the genetic causes of
nanophthalmos with a molecular-genetic study of a sin-
gle large kindred noted to have an unusually high in-
cidence of high hyperopia and frequent occurrence
of angle-closure glaucoma. As a first step toward iden-
tification of the disease gene and the underlying causes
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Figure 1 Nanophthalmos pedigree UM:181. Squares indicate males, and circles indicate females. Subjects with nanophthalmos are indicated
by blackened symbols, those with intermediate phenotypes are indicated by cross-hatched symbols, and those with no known eye disease are
indicated by unblackened symbols. The proband is indicated by an arrow. Deceased individuals are indicated by a diagonal line through the
symbol. Numbered individuals were examined by the authors, as described in Subjects and Methods. Genotypes for individuals 1–15, 17–19,
21, 22, 24–27, 29, 31, 32, 34, and 35 were used in the analyses. This family is part of a much larger family from which recruitment is continuing.
of aberrant eye development in this family, we charac-
terized the ocular features of each family member par-
ticipating in the study, evaluated the mode of inheri-
tance, and conducted a genome scan to search for genetic
markers that cosegregate with the disease phenotype.
Linkage and haplotype analyses of the resulting phe-
notypic and genotypic data provided strong evidence
that a locus on chromosome 11 is responsible for au-
tosomal dominant nanophthalmos in this family.
Subjects and Methods
Subjects
Thirty-five individuals in family UM:181 (fig. 1) were
evaluated by ophthalmologic examination by three of
the authors (D.A.C., G.L.S., and S.A.S.). Family mem-
bers examined included 27 at-risk descendants of the
affected founder and 8 unaffected spouses of affected
family members. Complete ophthalmologic examination
included refraction (reported as the spherical equivalent,
in diopters), keratometry, slit-lamp biomicrosopy, goni-
oscopy, measurement of intraocular pressure, optic-disc
evaluation, and A-scan ultrasonography to determine
axial length. The ages of the affected individuals in-
cluded in the genotyping and the analysis were within
the range 7–77 years (mean 28.3 years).
Genotyping
Genomic DNA isolated by use of the Puregene kit
(Gentra Systems), from 3-ml aliquots of whole blood,
was diluted to a concentration of 50 ng/ml. AmpliTaq
gold was used, in accordance with the manufacturer’s
recommended protocols (Perkin Elmer), to perform PCR
amplifications in 15-ml reaction mixtures (Mullis and
Faloona 1987). The microsatellite repeat markers as-
sayed included 345 markers from the 22 autosomes (ABI
Prism Linkage Mapping Panels). One of each pair of
primers was labeled with phosphoramidite fluorescent
tags, for use on an ABI377 semiautomated sequencer.
Thermal cycling in a GeneAmp 9600 or a GeneAmp
9700 (Perkin Elmer) thermal cycler was performed at
95C for 10–12 min, followed by 10 cycles at 94C for
15 s, 55C for 15 s, and 72C for 30 s and 20 cycles at
89C for 15 s, 55C for 15 s, and 72C for 30 s, followed
by a 10–30 min extension at 72C and a hold at 4C.
For the genome scan, multiplex loading of fragments
with different dye labels that migrate in different size
bins allowed simultaneous scoring of up to 14 fragments
per lane. The resulting PCR products were denatured,
size fractionated, and analyzed on 4% denaturing ac-
rylamide run on an ABI377 semiautomated sequencer.
GS350 or GS500 size standards were used as internal
standards that were run in the same lane with the mark-
ers. Alleles read and scored by use of GeneScan and
Genotyper software (ABI Perkin Elmer) were confirmed
by eye. Analysis of 132 markers was completed before
we identified linkage to the chromosome 11 markers.
After the genome scan, some additional markers (Dib et
al. 1996; Ge´ne´thon; Genome Database) were assayed by
radioactive labeling and autoradiography, as described
elsewhere (Richards et al. 1994), to further reduce the
chromosome 11 genetic inclusion interval (D11S1776,
D11S903, D11S1313, and D11S4191) and to exclude
the congenital microphthalmia locus on chromosome 14
(D14S977 and D14S1054). Amplification was per-
formed in 10-ml reaction volumes, for 30–35 cycles, by
use of the thermal-cycling conditions described by Mor-
issette et al. (1995).
Statistical Methods
Two-point linkage analysis was performed with the
MENDEL program (Lange et al. 1988), in accordance
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Table 1
Two-Point LOD Scores for Linkage between Nanophthalmos and Chromosome 11 Markers in
Family UM:181
MARKER
LOD SCORE AT v 
ˆv ˆZ v(2).00 .01 .05 .10 .20 .30 .40
D11S1338  5.00 1.76 .57 .27 .45 .32 .30 .45 .04
D11S902  4.51 1.28 .13 .64 .72 .48 .27 .74 .03
D11S904  3.76 1.16 .20 .45 .55 .38 .28 .56 .02
D11S1776  3.20 3.56 3.43 2.81 1.96 .97 .05 3.56 .00
D11S935  .23 .36 .53 .56 .45 .26 .16 .58 .00
D11S905  3.51 3.86 3.71 3.04 2.14 1.05 .05 3.86 .00
D11S903 5.92 5.83 5.44 4.94 3.85 2.65 1.31 .00 5.92 .00
D11S1313 4.10 4.03 3.75 3.39 2.62 1.77 .83 .00 4.10 .00
D11S4191 4.60 4.54 4.26 3.88 3.04 2.07 1.00 .00 4.60 .00
D11S987  2.39 2.81 2.74 2.26 1.57 .74 .06 2.81 .00
D11S1314  .62 2.22 2.64 2.51 1.88 .96 .13 2.68 .00
D11S937  .13 1.52 2.00 2.01 1.53 .78 .15 2.09 .00
D11S901  1.07 .64 1.19 1.37 1.10 .60 .18 1.38 .00
D11S1358  2.48 .08 .75 1.18 1.02 .58 .21 1.18 .01
D11S898  4.31 1.65 .62 .15 .32 .20 .30 .32 .04
D11S908  5.98 2.67 1.41 .42 .09 .02 .50 .00 .07
NOTE.—Linkage analyses were performed under the assumption of an autosomal dominant mode
of inheritance with complete penetrance and a disease-allele frequency of .01.
Table 2
Two-Point LOD Scores for Linkage between Angle-Closure Glaucoma and Chromosome 11
Markers in Family UM:181
MARKER
LOD SCORE AT v 
ˆv ˆZ v(2).00 .01 .05 .10 .20 .30 .40
D11S1338  6.52 3.16 1.83 .68 .19 .00 .45 .02 .09
D11S902  6.36 3.04 1.70 .56 .09 .07 .42 .07 .08
D11S904  4.54 1.91 .90 .10 .17 .17 .35 .20 .04
D11S1776  .63 1.15 1.23 1.05 .71 .33 .09 1.23 .00
D11S935 .32 .30 .26 .22 .16 .10 .05 .50 .00 .00
D11S905  1.43 1.91 1.93 1.61 1.12 .52 .08 1.94 .00
D11S903 3.21 3.16 2.93 2.64 2.02 1.34 .63 .00 3.21 .00
D11S1313 1.69 1.66 1.52 1.35 .99 .60 .23 .00 1.69 .00
D11S4191 3.09 3.04 2.82 2.54 1.94 1.29 .60 .00 3.09 .00
D11S987 2.05 2.01 1.85 1.65 1.23 .77 .30 .00 2.05 .00
D11S1314  .05 .99 1.29 1.28 .94 .46 .14 1.34 .00
D11S937  .29 .78 1.10 1.13 .85 .41 .15 1.17 .00
D11S901  1.16 .04 .36 .55 .47 .26 .20 .55 .00
D11S1358  .86 .24 .62 .76 .62 .34 .18 .76 .00
D11S898  1.63 .35 .08 .32 .27 .12 .22 .32 .00
D11S908  4.99 2.34 1.32 .50 .20 .09 .50 .00 .06
NOTE.—Linkage analyses were performed under the assumption of an autosomal dominant mode
of inheritance with complete penetrance and a disease-allele frequency of .01.
with the LOD-score method (Morton 1955). Multipoint
likelihoods were calculated with the VITESSE program
(O’Connell and Weeks 1995). Allele frequencies were
estimated from family data, as described elsewhere
(Boehnke 1991). Linkage analyses were performed un-
der a model of autosomal dominant inheritance with
complete penetrance and a disease-allele frequency of
.01. In tables 1–3, the column “v(2)” indicates the
largest recombination fraction (v) at which linkage may
be excluded on the basis of a LOD score !2.00. isˆv
the recombination fraction at which the estimated max-
imum LOD score is observed.ˆZ
For the linkage study, the criteria for assignment of
affected status included axial length !20.00 mm and
refractive error 17.00 diopters. For the genome scan,
angle-closure glaucoma or occludable anterior-chamber
angles were not part of the criteria for assignment of
affected status. Individuals were considered unaffected
if they had axial length 121.00 mm, refractive error
!4.00 diopters, and no evidence of angle-closure glau-
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Table 3
Two-Point LOD Scores for Linkage between Nanophthalmos and Chromosome 14 Markers in
Family UM:181
MARKER
LOD SCORE AT v 
ˆv ˆZ v(2).00 .01 .05 .10 .20 .30 .40
D14S261  5.69 2.50 1.23 .21 .14 .18 .36 .19 .06
D14S70  19.48 10.57 6.88 3.44 1.67 .61 .50 .00 .27
D14S276  11.42 5.94 3.69 1.64 .66 .16 .50 .00 .17
D14S63  5.95 2.64 1.38 .37 .00 .09 .40 .09 .07
D14S258  11.80 5.76 3.36 1.31 .43 .05 .47 .01 .15
D14S74  4.33 1.92 1.03 .33 .05 .04 .41 .04 .04
D14S68  4.67 2.02 .99 .17 .11 .14 .36 .15 .05
D14S280  1.48 .77 .43 .07 .09 .11 .36 .12 .00
D14S977  8.37 3.87 2.11 .65 .06 .12 .41 .12 .10
D14S1054  7.24 3.37 1.84 .59 .12 .02 .43 .02 .09
D14S65  3.11 1.20 .43 .13 .24 .17 .30 .24 .02
D14S78  8.85 4.17 2.33 .78 .16 .06 .43 .06 .11
D14S292  11.11 5.69 3.51 1.57 .66 .20 .50 .00 .16
NOTE.—Linkage analysis excluded the CMIC locus in the 12.6-cM D14S977–D14S1054–D14S65
interval.
coma or occludable anterior-chamber angles. Individuals
of intermediate phenotype were scored as undesignated.
Once linkage to chromosome 11 markers was detected,
two-point linkage analysis was repeated by use of a more
stringent phenotype in which only individuals with an-
gle-closure glaucoma or occludable anterior-chamber
angles were considered to be affected. The results of both
analyses for the chromosome 11 markers are shown in
tables 1 and 2. Flanking markers identified by linkage
analysis were confirmed by haplotype analysis (fig. 3).
Results
In family UM:181, nanophthalmos is inherited in an
autosomal dominant manner (fig. 1). Objective measures
of axial length (measured from front to back of the eye)
and refraction (amount of optical correction required
for best achievable vision) readily distinguish affected
individuals from unaffected individuals. Affected family
members demonstrated high hyperopia, within the range
7.25–13.00 diopters (mean9.88 diopters). In com-
parison, the emmetropic (normal) eye has a refraction
of 1.00–1.00 diopters. In general, someone with a
refraction outside of this range will require corrective
lenses for some or all of their daily visual tasks. In af-
fected family members, the mean axial length was re-
duced to 18.13 mm (range 17.55–19.28 mm), which is
!80% of the mean axial length of 23.37 mm in the
normal individuals described by Francois and Goes
(1977). Angle-closure glaucoma or occludable anterior-
chamber angles, present in 12 of the 22 affected indi-
viduals, represent later stages of progression of the
phenotype but are not necessary to identify affected in-
dividuals. Eleven unaffected subjects in the study had
open angles, refraction of 1.38–3.38 diopters, and
axial length of 21.26–24.48 mm. Two borderline sub-
jects were not included in the linkage study.
Two-point linkage analysis provided strong evidence
for linkage of the nanophthalmos phenotype to marker
D11S903 ( at ) and four other nearbyˆ ˆZ  5.92 v  .00
markers (table 1). Multipoint analysis revealed a max-
imum LOD score of 6.31 at D11S1313 (fig. 2). Both
linkage analysis and haplotyping indicate that this locus,
called “NNO1” (Genome Database Nomenclature
Committee), is located within a 14.7-cM genetic inclu-
sion interval framed by recombination events at
D11S905 and D11S987. The distal boundary of the in-
terval was defined by a recombination event between
D11S4191 and D11S987 that was observed in individ-
ual 35 (fig. 3). Similarly, the proximal boundary of the
interval is based on a recombination event between
D11S905 and D11S903 that was detected on the chro-
mosome that individual 35 inherited from individual 23
(fig. 3). When the phenotype was limited to angle-closure
glaucoma and/or occludable angles, the level of signifi-
cance of the linkage observation was reduced but still
significant, with LOD scores 13.0 for two of the markers
( at for D11S903, and atˆ ˆ ˆZ  3.21 v  .00 Z  3.09
for D11S4191; table 2). Our linkage results ex-ˆv  .00
clude the autosomal recessive congenital microphthal-
mia locus (CMIC; MIM 251600), which has been lo-
calized between D14S987 and D14S267 on chromo-
some 14q32 (Bessant et al. 1998; table 3).
Since nanophthalmos can be scored based solely on
the basis of objective characteristics that are evident even
in very young family members, we were able to recruit
a large number of affected participants who would have
been excluded from a study aimed at mapping the angle-
closure–glaucoma phenotype. Thus, although angle-clo-
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Figure 2 Multipoint analysis of markers immediately around the NNO1 locus. Dots represent locations for which multipoint LOD scores
were calculated, to determine linkage between nanophthalmos and the marker map D11S905–3.8 cM–D11S903–3.8 cM–D11S1313–0.1
cM–D11S4191–7.0 cM–D11S987. Dotted lines indicate the positions of these markers. Only one dotted line is shown for D11S1313 and
D11S4191, because they are so close together. LOD scores of  at D11S905 and D11S987 are not shown.
sure glaucoma is a potentially serious consequence of
nanophthalmos, for many family members, the age-de-
pendent penetrance of glaucoma would have caused loss
of useful information if angle-closure glaucoma had been
the primary trait scored for the genome scan.
Discussion
Linkage analysis of data from the genome scan pro-
vided very strong evidence that a genetic defect on chro-
mosome 11, between D11S905 and D11S987, is re-
sponsible for autosomal dominant nanophthalmos in
family UM:181. The genome scan that mapped this
NNO1 locus was performed by use of the limited set of
objective measures of nanophthalmos as the basis for
assignment of affected status. We also found significant
evidence that markers from this region of 11p are linked
to the more severe late-stage phenotype of angle-closure
glaucoma/occludable anterior-chamber angles found in
this family. The mapping of both traits, nanophthalmos
and angle-closure glaucoma, to the same locus is con-
sistent with previous reports that angle-closure glau-
coma is highly associated with nanophthalmos (Brock-
hurst 1974; Kimbrough et al. 1979).
The NNO1 defect produces a set of ocular charac-
teristics that include high hyperopia, short axial length,
and predisposition to angle-closure glaucoma, in family
UM:181. Most affected family members began wearing
glasses at preschool age, sometimes as early as 1 year of
age, and some family members appear to have ambly-
opia. More than half of the affected family members
have been diagnosed with angle-closure glaucoma or an-
terior-chamber angles that are narrow enough to be in
danger of angle closure. A substantial number of the
affected individuals in the first and second generations
of family UM:181 have suffered significant visual loss
from angle-closure glaucoma and complications of oc-
ular surgery. Some younger family members have already
undergone laser surgery. Even with intervention and
careful monitoring, they are still at risk for progressive
glaucomatous damage and visual loss.
The clinical characteristics, mode of inheritance, and
map location indicate that the NNO1 locus is distinct
from the congenital microphthalmia locus on 14q32
(MIM 251600; Bessant et al. 1998), the locus for Lenz
microphthalmia (MIM 309800; Lenz 1955; Ogunye et
al. 1975), and that for oculodentodigital syndrome
(MIM 164200; Rajic and De Veber 1966; Gladwin et
al. 1997). Clinical features and mode of inheritance sug-
gest that UM:181 nanophthalmos is a different pheno-
1416 Am. J. Hum. Genet. 63:1411–1418, 1998
Figure 3 Haplotype analysis. Squares indicate males, and circles
indicate females. The individual numbers correspond to the individual
numbers in the pedigree in fig. 1. Subjects with nanophthalmos are
indicated by blackened symbols, and those with no known eye disease
are indicated by unblackened symbols. Alleles of the disease gene–
bearing haplotype are contained within the boxed portions of the hap-
lotypes. At the time these markers were run, DNA was not available
from individual 23, the father of individuals 34 and 35.
type, rather than a form of retinal degeneration with
nanophthalmos, cystic macular degeneration, and angle-
closure glaucoma (MIM 267760), described by MacKay
and colleagues (1987). Because the glaucoma in nanoph-
thalmos results from an angle-closure mechanism, it is
not surprising that our data also exclude the reported
primary open-angle glaucoma loci GLC1A (MIM
137750; Sheffield et al. 1993), GLC1B (MIM 137760;
Stoilova et al. 1996), GLC1C (MIM 601682; Wirtz et
al. 1997), and GLC1D (MIM 602429; Trifan et al.,
1998). Testing of other nanophthalmos families, with
markers in the immediate vicinity of the NNO1 locus,
will allow us to test for genetic heterogeneity for nanoph-
thalmos. Testing of other families with related but dif-
ferent phenotypes will allow us to determine whether
less severe forms of hyperopia or other forms of angle-
closure glaucoma might also map to this locus.
Nanophthalmos is thought to result from the arrested
development of the eye during the embryonic stage
(Duke-Elder 1964), but the specific underlying genetic
and biochemical causes are unknown. Studies of animal
models and hereditary human ocular disorders indicate
that multiple transcriptional activators play important
roles in eye development in animal model systems, but
the factors that determine globe size in humans are not
well understood (Jordan et al. 1992; Burmeister et al.
1996; Sanyanusin et al. 1995; Graw 1996; Belecky-Ad-
ams et al. 1997; Furukawa et al. 1997; Freund et al.
1998). Thickened sclera is a common manifestation of
nanophthalmos, and some studies have reported unusual
collagen bundles and aberrant glycosaminoglycan me-
tabolism in some, but not all, cases (Yue et al. 1988;
David et al. 1990; Shiono et al. 1992). However, the
relationship of these aberrant structural and metabolic
properties to the causes of human nanophthalmos re-
mains poorly defined.
Owing to the apparently developmental nature of the
NNO1 defect, we were interested to find that one of the
genes located on 11 is the PAX6 gene (MIM 106210),
a homeodomain gene that produces a protein known to
play a critical role in ocular development in mice and
humans (Graw 1996; Tomarev 1997; Tang et al. 1998).
The mouse Pax6 gene has been implicated in the phe-
notype “small eye” in mice, but reduced globe size is
not a feature of aniridia (MIM 106210; Mouse Genome
Informatics) or of the several other ocular phenotypes
reported for PAX6 defects in humans (MIM 106210;
Jordan et al. 1992; Glaser et al. 1994a; Hanson et al.
1994; Mirzayans et al. 1995; Azuma et al. 1996; Schedl
et al. 1996). In the Unigene Human Sequence Collection
database (National Center for Biotechnology Informa-
tion), the PAX6 UniGene cluster, Hs.89506, is located
in the 38–42-cM region of chromosome 11 between
markers D11S1324 and D11S914. The proximal marker
for this bin, D11S914, is 12 cM telomeric to D11S905,
the distal flanking marker for the NNO1 interval (Dib
et al. 1996). Glaser and colleagues (1994b) used somatic-
cell hybrids containing deletions in human chromosome
11 to place PAX6 distal to D11S907, which is 8.1 cM
distal to D11S905 (Dib et al. 1996). Thus, a defect in
PAX6 appears to be ruled out as the cause of nano-
phthalmos in family UM:181, on the basis of the place-
ment of PAX6 outside of the NNO1 genetic inclusion
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interval. We are continuing our evaluation of additional
genes in the region as potential NNO1 candidates, in-
cluding more precise localization of genes for which pre-
vious placements are approximate.
The mapping of the NNO1 locus is the first step to-
ward the identification of the gene itself. When the gene
is known, genetic testing of at-risk individuals will be
possible, allowing early detection and treatment. Such
testing may be particularly beneficial with respect to
early treatment of children with hyperopia, to prevent
amblyopia. Testing also would identify individuals in
need of long-term follow-up to monitor for development
of angle-closure glaucoma. In addition to providing in-
formation about the first genetically mapped form of
autosomal dominant nanophthalmos, identification of
the NNO1 gene should provide further insights into fun-
damental aspects of ocular development.
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